<p><strong>在《危重症探索》上發表的研究強調了單孔導管設計對高碳酸血癥患者的益處 1</strong></p>
<p>, /PRNewswire/ -- Vapotherm, Inc.，全球領先的無面罩非侵入性呼吸支持公司，自豪地宣佈在《危重症探索》上發表了一項新的臨牀研究，題為《高流速治療的單孔導管設計效果：在較低氣體流量下的可比療效》。該研究表明，ProSoft® Unicorn™ 導管作為一種單孔高流速治療導管，在顯著較低的流量下提供了與傳統雙孔導管相當的呼吸困難緩解效果。</p>
<p>該研究由查爾斯·阿特伍德博士領導，評估了 26 名高碳酸血癥慢性阻塞性肺病（COPD）患者的隨機交叉試驗。結果顯示，使用獨角獸導管的患者在中位流量僅為 15 LPM 時體驗到的呼吸困難緩解效果與傳統雙孔導管的 25 LPM 相當。</p>
<p>“鼻導管的孔徑大小很重要。通過用高流速的新鮮氣體沖洗上呼吸道的死腔，HVT 改善了通氣並減少了呼吸的工作量，” Vapotherm 首席醫療官傑西卡·惠特爾博士説。“作為一名急診醫生，看到單孔導管在成人患者中得到應用，令人感到非常興奮——包括那些有鼻骨骨折、唇齶裂、鼻胃管和其他挑戰的患者。”</p>
<p><strong>呼吸護理效率的新標準</strong></p>
<p>該研究的一個重要發現是氧氣節約的潛力，使獨角獸導管成為鄉村醫院、國際醫療環境和未來需要有效治療的居家患者的理想選擇，同時減少氧氣消耗。</p>
<p>“我們很高興看到獨角獸導管在較低流量下提供相同的臨牀益處，” Vapotherm 總裁兼首席執行官喬·阿米説。“對於氧氣有限的設施、醫院內患者的轉運以及居家患者，這意味着一種更可持續和舒適的治療選擇。全天更換鼻孔的患者可能會體驗到更少的刺激，從而提高依從性——同時保持有效的二氧化碳清除。”</p>
<p><strong>研究的關鍵要點：</strong></p>
<ul>
<li><strong>在較低流量下可比的呼吸困難緩解：</strong> 獨角獸導管在較低流量下實現了與傳統雙孔導管相似的呼吸困難緩解效果。</li>
<li><strong>增強的舒適性和多功能性：</strong> 獨角獸導管是面部畸形、創傷患者和需要鼻胃管的患者的選擇，為雙孔系統提供了有效的替代方案。</li>
<li><strong>增加的舒適性可能意味着未來居家患者的依從性提高：</strong> 單孔設計允許患者在兩個鼻孔之間交替使用，以減少刺激。</li>
</ul>
<p><strong>擴展對高流速治療的臨牀理解</strong></p>
<p>該研究現已在《危重症探索》上發佈，進一步支持高流速治療作為自發呼吸患者非侵入性通氣的替代方案。</p>
<p>有興趣瞭解更多的醫療專業人士可以在此訪問完整出版物：<em>危重症探索研究鏈接</em></p>
<p>有關獨角獸導管的更多信息或探索其如何增強患者護理，請訪問 Vapotherm.com 或聯繫 [email protected] 以獲取任何問題。</p>
<p><strong>關於 Vapotherm</strong></p>
<p>Vapotherm, Inc. 總部位於新罕布什爾州埃克塞特，致力於通過創新和臨牀卓越改善呼吸護理。通過開發高流速治療等先進解決方案，Vapotherm 使醫療提供者能夠提供卓越的患者結果，同時提升護理體驗並降低整體護理成本。</p>
<ol>
<li>Atwood, Charles MD; Sethi, Jigme MD; Bergeski, Amy MHA, RRT-NPS; Dungan, George C. II MPhil (Med); Volakis, Leonithas I. MS, PhD; Whittle, Jessica S. MD, PhD. 高流速治療的單孔導管設計效果：在較低氣體流量下的可比療效。《危重症探索》7(2):p e1209, 2025 年 2 月。| DOI: 10.1097/CCE.0000000000001209</li>
</ol>
<p>來源 Vapotherm, Inc.</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNTIwJk5ld3NJdGVtSWQ9REM5MTEyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA1MjAwNjMwUFJfTkVXU19VU1BSX19fX19EQzkxMTIx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNTIwJk5ld3NJdGVtSWQ9REM5MTEyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA1MjAwNjMwUFJfTkVXU19VU1BSX19fX19EQzkxMTIx"/></p>

VAPO

<p>Vapotherm, Inc. 宣佈了一項新的臨牀研究，該研究發表在《重症監護探索》期刊上，表明其 ProSoft® Unicorn™ 導管在較低流量（15 LPM）下提供的呼吸困難緩解效果與傳統雙孔導管（25 LPM）相當。該研究由 Charles Atwood 醫生主導，涉及 26 名高碳酸血癥的慢性阻塞性肺病患者，突顯了該導管對面部畸形患者和需要鼻胃管的患者的益處。研究結果表明，可能實現氧氣節約，使其適合農村醫院和居家護理環境，提高患者的舒適度和依從性</p>

<p><strong>Published Research in <em>Critical Care Explorations</em> Highlights Benefits of Single-Prong Cannula Design for Hypercapnic Patients1</strong></p>
<div class="lb-trans"><p><strong>在《危重症探索》上發表的研究強調了單孔導管設計對高碳酸血癥患者的益處 1</strong></p>
</div><p>, /PRNewswire/ -- Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, <em>Effect of Single-Prong Cannula Design with High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates</em>, in <em>Critical Care Explorations</em>. The study demonstrates that the ProSoft® Unicorn™ Cannula, a single-prong high velocity therapy cannula, provides comparable relief of dyspnea at significantly lower flow rates compared to traditional dual-prong cannulas.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Vapotherm, Inc.，全球領先的無面罩非侵入性呼吸支持公司，自豪地宣佈在《危重症探索》上發表了一項新的臨牀研究，題為《高流速治療的單孔導管設計效果：在較低氣體流量下的可比療效》。該研究表明，ProSoft® Unicorn™ 導管作為一種單孔高流速治療導管，在顯著較低的流量下提供了與傳統雙孔導管相當的呼吸困難緩解效果。</p>
</div><p>The study, led by Dr. Charles Atwood, evaluated 26 hypercapnic COPD patients in a randomized crossover trial. The results showed that patients using the Unicorn Cannula experienced comparable relief of dyspnea at a median flow rate of just 15 LPM, compared to 25 LPM for traditional dual-prong cannulas.</p>
<div class="lb-trans"><p>該研究由查爾斯·阿特伍德博士領導，評估了 26 名高碳酸血癥慢性阻塞性肺病（COPD）患者的隨機交叉試驗。結果顯示，使用獨角獸導管的患者在中位流量僅為 15 LPM 時體驗到的呼吸困難緩解效果與傳統雙孔導管的 25 LPM 相當。</p>
</div><p>&#34;The bore-size of a nasal cannula matters. By flushing the upper airway dead space with high velocity fresh gas, HVT improves ventilation and reduces the work of breathing,&#34; said Dr. Jessica Whittle, Chief Medical Officer at Vapotherm. &#34;As a practicing emergency physician, it's so exciting to see a single prong cannula in the adult space for all patients – including those with broken noses, cleft palates, NG tubes, and other challenges.&#34;</p>
<div class="lb-trans"><p>“鼻導管的孔徑大小很重要。通過用高流速的新鮮氣體沖洗上呼吸道的死腔，HVT 改善了通氣並減少了呼吸的工作量，” Vapotherm 首席醫療官傑西卡·惠特爾博士説。“作為一名急診醫生，看到單孔導管在成人患者中得到應用，令人感到非常興奮——包括那些有鼻骨骨折、唇齶裂、鼻胃管和其他挑戰的患者。”</p>
</div><p><strong>A New Standard for Efficiency in Respiratory Care</strong></p>
<div class="lb-trans"><p><strong>呼吸護理效率的新標準</strong></p>
</div><p>One of the most significant findings of the study is the potential for oxygen conservation, making the Unicorn Cannula an ideal option for rural hospitals, international healthcare settings, and future home care patients who need effective therapy while reducing oxygen consumption.</p>
<div class="lb-trans"><p>該研究的一個重要發現是氧氣節約的潛力，使獨角獸導管成為鄉村醫院、國際醫療環境和未來需要有效治療的居家患者的理想選擇，同時減少氧氣消耗。</p>
</div><p>&#34;We're excited to see the Unicorn Cannula delivering the same clinical benefit at lower flow rates,&#34; said Joe Army, President and CEO of Vapotherm. &#34;For oxygen-limited facilities, transport of patients within the hospital, and for home patients, this can mean a more sustainable and comfortable therapy option. Patients who switch nostrils throughout the day may experience less irritation leading to greater compliance—all while maintaining effective CO₂ clearance.&#34;</p>
<div class="lb-trans"><p>“我們很高興看到獨角獸導管在較低流量下提供相同的臨牀益處，” Vapotherm 總裁兼首席執行官喬·阿米説。“對於氧氣有限的設施、醫院內患者的轉運以及居家患者，這意味着一種更可持續和舒適的治療選擇。全天更換鼻孔的患者可能會體驗到更少的刺激，從而提高依從性——同時保持有效的二氧化碳清除。”</p>
</div><p><strong>Key Takeaways from the Study:</strong></p>
<div class="lb-trans"><p><strong>研究的關鍵要點：</strong></p>
</div><ul>
<li><strong>Comparable Dyspnea Relief at Lower Flow Rates:</strong> The Unicorn Cannula achieved similar dyspnea relief as traditional dual-prong cannulas at lower flow rates.</li>
<li><strong>Enhanced Comfort and Versatility:</strong> The Unicorn Cannula is an option for patients with facial deformities, trauma and for those requiring nasogastric tubes, offering an effective alternative to dual-prong systems.</li>
<li><strong>Increased Comfort may mean increased Compliance for Future Home Patients:</strong> The single-prong design allows patients to alternate the nasal prong from one naris to the other to minimize irritation.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>在較低流量下可比的呼吸困難緩解：</strong> 獨角獸導管在較低流量下實現了與傳統雙孔導管相似的呼吸困難緩解效果。</li>
<li><strong>增強的舒適性和多功能性：</strong> 獨角獸導管是面部畸形、創傷患者和需要鼻胃管的患者的選擇，為雙孔系統提供了有效的替代方案。</li>
<li><strong>增加的舒適性可能意味着未來居家患者的依從性提高：</strong> 單孔設計允許患者在兩個鼻孔之間交替使用，以減少刺激。</li>
</ul>
</div><p><strong>Expanding the Clinical Understanding of High-Velocity Therapy</strong></p>
<div class="lb-trans"><p><strong>擴展對高流速治療的臨牀理解</strong></p>
</div><p>The study, now available in <em>Critical Care Explorations</em>, adds to the growing body of evidence supporting high velocity therapy as an alternative to non-invasive ventilation, for spontaneously breathing patients.</p>
<div class="lb-trans"><p>該研究現已在《危重症探索》上發佈，進一步支持高流速治療作為自發呼吸患者非侵入性通氣的替代方案。</p>
</div><p>Healthcare professionals interested in learning more can access the full publication here: <em>Critical Care Explorations Study Link</em></p>
<div class="lb-trans"><p>有興趣瞭解更多的醫療專業人士可以在此訪問完整出版物：<em>危重症探索研究鏈接</em></p>
</div><p>For more information about the Unicorn Cannula or to explore how it can enhance patient care, visit Vapotherm.com or contact [email protected] for any questions.</p>
<div class="lb-trans"><p>有關獨角獸導管的更多信息或探索其如何增強患者護理，請訪問 Vapotherm.com 或聯繫 [email protected] 以獲取任何問題。</p>
</div><p><strong>About Vapotherm</strong></p>
<div class="lb-trans"><p><strong>關於 Vapotherm</strong></p>
</div><p>Vapotherm, Inc. based in Exeter, NH, is dedicated to improving respiratory care through innovation and clinical excellence. By developing advanced solutions like high velocity therapy, Vapotherm empowers healthcare providers to deliver superior patient outcomes while enhancing the care experience and reducing the total cost of care.</p>
<div class="lb-trans"><p>Vapotherm, Inc. 總部位於新罕布什爾州埃克塞特，致力於通過創新和臨牀卓越改善呼吸護理。通過開發高流速治療等先進解決方案，Vapotherm 使醫療提供者能夠提供卓越的患者結果，同時提升護理體驗並降低整體護理成本。</p>
</div><ol>
<li>Atwood, Charles MD; Sethi, Jigme MD; Bergeski, Amy MHA, RRT-NPS; Dungan, George C. II MPhil (Med); Volakis, Leonithas I. MS, PhD; Whittle, Jessica S. MD, PhD. Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates. Critical Care Explorations 7(2):p e1209, February 2025. | DOI: 10.1097/CCE.0000000000001209</li>
</ol>
<div class="lb-trans"><ol>
<li>Atwood, Charles MD; Sethi, Jigme MD; Bergeski, Amy MHA, RRT-NPS; Dungan, George C. II MPhil (Med); Volakis, Leonithas I. MS, PhD; Whittle, Jessica S. MD, PhD. 高流速治療的單孔導管設計效果：在較低氣體流量下的可比療效。《危重症探索》7(2):p e1209, 2025 年 2 月。| DOI: 10.1097/CCE.0000000000001209</li>
</ol>
</div><p>SOURCE Vapotherm, Inc.</p>
<div class="lb-trans"><p>來源 Vapotherm, Inc.</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNTIwJk5ld3NJdGVtSWQ9REM5MTEyMSZUcmFuc21pc3Npb25fSWQ9MjAyNTA1MjAwNjMwUFJfTkVXU19VU1BSX19fX19EQzkxMTIx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC91121&amp;Transmission_Id=202505200630PR_NEWS_USPR_____DC91121&amp;DateId=20250520"/></p>

新的研究證實 Vapotherm 的 Unicorn™鼻導管在較低流速下提供了相當的療效